Spyre Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2015 | 1.5M |
| FY2016 | 26.9M |
| FY2017 | 33.3M |
| FY2018 | 48.3M |
| FY2019 | 58.2M |
| FY2020 | 106.7M |
| FY2021 | 2.6M |
| FY2022 | 3.4M |
| FY2023 | 6.9M |
| FY2024 | 60.3M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2015 | 1.5M |
| FY2016 | 26.9M |
| FY2017 | 33.3M |
| FY2018 | 48.3M |
| FY2019 | 58.2M |
| FY2020 | 106.7M |
| FY2021 | 2.6M |
| FY2022 | 3.4M |
| FY2023 | 6.9M |
| FY2024 | 60.3M |